Breaking News, Promotions & Moves

Rentschler Biopharma Names Martin Kessler as New CEO in U.S.

Will drive company-wide transformation and lead the ongoing expansion at the U.S. site.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Rentschler Biopharma SE, a global contract development and manufacturing organization (CDMO) for biopharmaceuticals, has appointed of Dr. Martin Kessler as CEO of Rentschler Biopharma Inc., the company’s wholly owned U.S. subsidiary, and as senior vice president of transformation of Rentschler Biopharma SE.   Kessler brings more than 15 years of experience in pharmaceutical and biopharmaceutical operations and strategy. At Rentschler Biopharma, he will drive the transformation throughout the com...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters